Antimicrobial Activity of Cefamandole Against Salmonella typhi

AUTOR(ES)

Hirschman, Shalom Z.

RESUMO

A patient with Salmonella typhi bacteremia was sucessfully treated with cefamandole, a new cephalosporin derivative. Infection has not recurred during 6 months of follow-up observation. Minimum inhibitory concentrations and minimum bactericidal concentrations of cefamandole, cephalothin, ampicillin, and chloramphenicol were compared against 26 strains of S. typhi. All the strains were susceptible to cefamandole in vitro. Seven of the strains were resistant to chloramphenicol, and another seven were resistant to both chloramphenicol and ampicillin. Cefamandole appears to warrant further clinical trial for the treatment of typhoid fever.

Documentos Relacionados

• Comparative In Vitro Appraisal of Piperacillin, Including Its Activity Against Salmonella typhi
• Cefamandole: Antimicrobial Activity In Vitro of a New Cephalosporin
• Comparison of In Vitro Antimicrobial Activity of Cefamandole and Cefazolin with Cephalothin Against over 8,000 Clinical Bacterial Isolates
• Construction of a recombinant oral vaccine against Salmonella typhi and Salmonella typhimurium.
• Antimicrobial activity of copper surfaces against suspensions of Salmonella enterica and Campylobacter jejuni